Munich, Germany

Gunther Ross


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • München, DE (2012)
  • Munich, DE (2013 - 2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gunther Ross: Innovator in Cancer Therapeutics

Introduction

Gunther Ross is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer therapy through his innovative inventions. With a total of 3 patents, Ross has focused on developing compounds that have therapeutic utility in treating various medical conditions.

Latest Patents

Ross's latest patents include groundbreaking work on Pyrrolidin-2-ones. This invention provides compounds that act as ligands binding to the HDM2 protein, inducing apoptosis and inhibiting proliferation. These compounds have therapeutic applications in cancer therapy and prevention. Additionally, they can be utilized for treating stroke, myocardial infarction, ischemia, multi-organ failure, spinal cord injury, Alzheimer's Disease, and heart valvular degenerative disease. Furthermore, these compounds can help decrease the side effects from cytotoxic cancer agents and radiation, as well as treat viral infections.

Another significant patent involves Tetrahydro-isoquinolines. This invention also provides compounds that serve as ligands binding to the HDM2 protein, with similar therapeutic applications as the Pyrrolidin-2-ones. These compounds are designed to address a range of serious health issues, including those related to ischemic events and degenerative diseases.

Career Highlights

Throughout his career, Gunther Ross has worked with prominent companies in the pharmaceutical industry, including Priaxon AG and Boehringer Ingelheim International GmbH. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Ross has collaborated with notable colleagues, including Christoph Burdack and Cedric Kalinski. These partnerships have likely enhanced his research and development efforts in the field of cancer therapeutics.

Conclusion

Gunther Ross is a distinguished inventor whose work in cancer therapy has the potential to make a significant impact on medical treatment. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…